Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017 (2017), Article ID 4108768, 8 pages
https://doi.org/10.1155/2017/4108768
Research Article

Hepatic Cholesterol-25-Hydroxylase Overexpression Improves Systemic Insulin Sensitivity in Mice

1Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria
2Laboratory of Gene Regulation and Signal Transduction, Departments of Pharmacology and Pathology, UCSD School of Medicine, San Diego, CA, USA
3Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany
4Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

Correspondence should be addressed to Elisa Einwallner; ta.ca.neiwinudem@renllawnie.asile

Received 13 November 2016; Revised 4 January 2017; Accepted 31 January 2017; Published 19 February 2017

Academic Editor: Toshiyasu Sasaoka

Copyright © 2017 Britta Noebauer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Managing Overweight and Obesity in Adults, Systematic Evidence Review from the Obesity Expert Panel 2013, http://www.nhlbi.nih.gov/sites/www.nhlbi.nih.gov/files/obesity-evidence-review.pdf.
  2. “Clinical Guidelines on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults,” http://www.nhlbi.nih.gov/files/docs/guidelines/ob_gdlns.pdf.
  3. J. M. Olefsky and C. K. Glass, “Macrophages, inflammation, and insulin resistance,” Annual Review of Physiology, vol. 72, pp. 219–246, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Stefan, H.-U. Häring, F. B. Hu, and M. B. Schulze, “Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications,” The Lancet Diabetes & Endocrinology, vol. 1, no. 2, pp. 152–162, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Tchkonia, T. Thomou, Y. Zhu et al., “Mechanisms and metabolic implications of regional differences among fat depots,” Cell Metabolism, vol. 17, no. 5, pp. 644–656, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. J.-H. Hwang, D. T. Stein, N. Barzilai et al., “Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies,” American Journal of Physiology—ndocrinology and Metabolism, vol. 293, no. 6, pp. E1663–E1669, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Stefan, K. Kantartzis, and H.-U. Häring, “Causes and metabolic consequences of fatty liver,” Endocrine Reviews, vol. 29, no. 7, pp. 939–960, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. B. L. Wajchenberg, “Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome,” Endocrine Reviews, vol. 21, no. 6, pp. 697–738, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. V. T. Samuel and G. I. Shulman, “Mechanisms for insulin resistance: common threads and missing links,” Cell, vol. 148, no. 5, pp. 852–871, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. R. V. Farese Jr., R. Zechner, C. B. Newgard, and T. C. Walther, “The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance,” Cell Metabolism, vol. 15, no. 5, pp. 570–573, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. K. F. Petersen and G. I. Shulman, “Cellular mechanism of insulin resistance in skeletal muscle,” Journal of the Royal Society of Medicine, Supplement, vol. 95, no. 42, pp. 8–13, 2002. View at Google Scholar · View at Scopus
  12. G. I. Shulman, “Cellular mechanisms of insulin resistance,” The Journal of Clinical Investigation, vol. 106, no. 2, pp. 171–176, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Fabbrini, F. Magkos, B. S. Mohammed et al., “Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 36, pp. 15430–15435, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Alkazemi, G. Egeland, J. Vaya, S. Meltzer, and S. Kubow, “Oxysterol as a marker of atherogenic dyslipidemia in adolescence,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 11, pp. 4282–4289, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. V. M. Olkkonen and M. Lehto, “Oxysterols and oxysterol binding proteins: role in lipid metabolism and atherosclerosis,” Annals of Medicine, vol. 36, no. 8, pp. 562–572, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Ziedén, A. Kaminskas, M. Kristenson et al., “Increased plasma 7β-hydroxycholesterol concentrations in a population with a high risk for cardiovascular disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 4, pp. 967–971, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Jakobsson, E. Treuter, J.-Å. Gustafsson, and K. R. Steffensen, “Liver X receptor biology and pharmacology: new pathways, challenges and opportunities,” Trends in Pharmacological Sciences, vol. 33, no. 7, pp. 394–404, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Töröcsik, A. Szanto, and L. Nagy, “Oxysterol signaling links cholesterol metabolism and inflammation via the liver X receptor in macrophages,” Molecular Aspects of Medicine, vol. 30, no. 3, pp. 134–152, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. D. J. Peet, B. A. Janowski, and D. J. Mangelsdorf, “The LXRs: a new class of oxysterol receptors,” Current Opinion in Genetics and Development, vol. 8, no. 5, pp. 571–575, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. J. R. Schultz, H. Tu, A. Luk et al., “Role of LXRs in control of lipogenesis,” Genes and Development, vol. 14, no. 22, pp. 2831–2838, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Tontonoz and D. J. Mangelsdorf, “Liver X receptor signaling pathways in cardiovascular disease,” Molecular Endocrinology, vol. 17, no. 6, pp. 985–993, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Traversari and V. Russo, “Control of the immune system by oxysterols and cancer development,” Current Opinion in Pharmacology, vol. 12, no. 6, pp. 729–735, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. N. J. Spann and C. K. Glass, “Sterols and oxysterols in immune cell function,” Nature Immunology, vol. 14, no. 9, pp. 893–900, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. J. J. Repa, G. Liang, J. Ou et al., “Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ,” Genes & Development, vol. 14, no. 22, pp. 2819–2830, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Grefhorst and E. J. Parks, “Reduced insulin-mediated inhibition of VLDL secretion upon pharmacologic alactivation of the liver X receptor in mice,” Journal of Lipid Research, vol. 50, no. 7, pp. 1374–1383, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Ren and Y. Ning, “Sulfation of 25-hydroxycholesterol regulates lipid metabolism, inflammatory responses, and cell proliferation,” American Journal of Physiology—Endocrinology and Metabolism, vol. 306, no. 2, pp. E123–E130, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Rosklint, B. G. Ohlsson, O. Wiklund, K. Norén, and L. M. Hultén, “Oxysterols induce interleukin-1β production in human macrophages,” European Journal of Clinical Investigation, vol. 32, no. 1, pp. 35–42, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. M. C. O. Englund, A.-L. K. Karlsson, O. Wiklund, G. Bondjers, and B. G. Ohlsson, “25-Hydroxycholesterol induces lipopolysaccharide-tolerance and decreases a lipopolysaccharide-induced TNF-α secretion in macrophages,” Atherosclerosis, vol. 158, no. 1, pp. 61–71, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. D. W. Russell, “Oxysterol biosynthetic enzymes,” Biochimica et Biophysica Acta, vol. 1529, no. 1–3, pp. 126–135, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. R. S. Holmes, J. L. VandeBerg, and L. A. Cox, “Genomics and proteomics of vertebrate cholesterol ester lipase (LIPA) and cholesterol 25-hydroxylase (CH25H),” 3 Biotech, vol. 1, no. 2, pp. 99–109, 2011. View at Publisher · View at Google Scholar
  31. E. G. Lund, T. A. Kerr, J. Sakai, W.-P. Li, and D. W. Russell, “cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism,” The Journal of Biological Chemistry, vol. 273, no. 51, pp. 34316–34327, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. U. Diczfalusy, K. E. Olofsson, A.-M. Carlsson et al., “Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide,” Journal of Lipid Research, vol. 50, no. 11, pp. 2258–2264, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. D. R. Bauman, A. D. Bitmansour, J. G. McDonald, B. M. Thompson, G. Liang, and D. W. Russell, “25-Hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A production,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 39, pp. 16764–16769, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Todoric, B. Strobl, A. Jais et al., “Cross-talk between interferon-γ and hedgehog signaling regulates adipogenesis,” Diabetes, vol. 60, no. 6, pp. 1668–1676, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Jais, E. Einwallner, O. Sharif et al., “Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man,” Cell, vol. 158, no. 1, pp. 25–40, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Hardy, M. Kitamura, T. Harris-Stansil, Y. Dai, and M. L. Phipps, “Construction of adenovirus vectors through Cre-lox recombination,” Journal of Virology, vol. 71, no. 3, pp. 1842–1849, 1997. View at Google Scholar · View at Scopus
  37. J. A. Pospisilik, C. Knauf, N. Joza et al., “Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes,” Cell, vol. 131, no. 3, pp. 476–491, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. O. Guillemot-Legris, V. Mutemberezi, P. D. Cani, and G. G. Muccioli, “Obesity is associated with changes in oxysterol metabolism and levels in mice liver, hypothalamus, adipose tissue and plasma,” Scientific Reports, vol. 6, Article ID 19694, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. W. Chen, G. Chen, D. L. Head, D. J. Mangelsdorf, and D. W. Russell, “Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice,” Cell Metabolism, vol. 5, no. 1, pp. 73–79, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Xie, E. G. Lund, S. D. Turley, D. W. Russell, and J. M. Dietschy, “Quantitation of two pathways for cholesterol excretion from the brain in normal mice and mice with neurodegeneration,” Journal of Lipid Research, vol. 44, no. 9, pp. 1780–1789, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Papassotiropoulos, D. Lütjohann, M. Bagli et al., “Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease,” NeuroReport, vol. 11, no. 9, pp. 1959–1962, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. V. Leonia, T. Mastermanc, U. Diczfalusy, G. De Lucaa, J. Hillertc, and I. Björkhem, “Changes in human plasma levels of the brain specific oxysterol 24S-hydroxycholesterol during progression of multiple sclerosis,” Neuroscience Letters, vol. 331, no. 3, pp. 163–166, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Kölsch, R. Heun, A. Kerksiek, K. V. Bergmann, W. Maier, and D. Lütjohann, “Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients,” Neuroscience Letters, vol. 368, no. 3, pp. 303–308, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. L. A. Shobab, G.-Y. R. Hsiung, and H. H. Feldman, “Cholesterol in Alzheimer's disease,” The Lancet Neurology, vol. 4, no. 12, pp. 841–852, 2005. View at Publisher · View at Google Scholar
  45. A. Solomon, V. Leoni, M. Kivipelto et al., “Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease,” Neuroscience Letters, vol. 462, no. 1, pp. 89–93, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. V. Leoni, J. D. Long, J. A. Mills, S. Di Donato, and J. S. Paulsen, “Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression,” Neurobiology of Disease, vol. 55, pp. 37–43, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. J. G. Cyster, E. V. Dang, A. Reboldi, and T. Yi, “25-Hydroxycholesterols in innate and adaptive immunity,” Nature Reviews Immunology, vol. 14, no. 11, pp. 731–743, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. U. Diczfalusy, “On the formation and possible biological role of 25-hydroxycholesterol,” Biochimie, vol. 95, no. 3, pp. 455–460, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. V. Bieghs, T. Hendrikx, P. J. Van Gorp et al., “The cholesterol derivative 27-hydroxycholesterol reduces steatohepatitis in mice,” Gastroenterology, vol. 144, no. 1, pp. 167.e1–178.e1, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Banerjee and M. Saxena, “Interleukin-1 (IL-1) family of cytokines: role in type 2 diabetes,” Clinica Chimica Acta, vol. 413, no. 15-16, pp. 1163–1170, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Reboldi, E. V. Dang, J. G. McDonald, G. Liang, D. W. Russell, and J. G. Cyster, “25-hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon,” Science, vol. 345, no. 6197, pp. 679–684, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. O. Osborn, S. E. Brownell, M. Sanchez-Alavez, D. Salomon, H. Gram, and T. Bartfai, “Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity,” Cytokine, vol. 44, no. 1, pp. 141–148, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. A. M. K. Choi and K. Nakahira, “Dampening insulin signaling by an NLRP3 ‘meta-flammasome’,” Nature Immunology, vol. 12, no. 5, pp. 379–380, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. R. Zhou, A. Tardivel, B. Thorens, I. Choi, and J. Tschopp, “Thioredoxin-interacting protein links oxidative stress to inflammasome activation,” Nature Immunology, vol. 11, no. 2, pp. 136–140, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. H. Wen, D. Gris, Y. Lei et al., “Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling,” Nature Immunology, vol. 12, no. 5, pp. 408–415, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. E. S. Gold, A. H. Diercks, I. Podolsky et al., “25-Hydroxycholesterol acts as an amplifier of inflammatory signaling,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 29, pp. 10666–10671, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. A. Koarai, S. Yanagisawa, H. Sugiura et al., “25-Hydroxycholesterol enhances cytokine release and toll-like receptor 3 response in airway epithelial cells,” Respiratory Research, vol. 13, article 63, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. F. T. Wunderlich, P. Ströhle, A. C. Könner et al., “Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action,” Cell Metabolism, vol. 12, no. 3, pp. 237–249, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. Z. K. Tuong, P. Lau, X. Du et al., “RORα and 25-hydroxycholesterol crosstalk regulates lipid droplet homeostasis in macrophages,” PLoS ONE, vol. 11, no. 1, Article ID e0147179, 2016. View at Publisher · View at Google Scholar · View at Scopus